We have already shown that angiopoietin-2 is the leader gene in the transcriptomic signature defining aggressiveness in HCC (14) and that this is linked to the powerful neoangiogenesis that develops in these patients. This evidence concerns the gene ANGPT2 and hepatocellular carcinoma.